0000950170-24-032237.txt : 20240315 0000950170-24-032237.hdr.sgml : 20240315 20240315163147 ACCESSION NUMBER: 0000950170-24-032237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pitt Justin D CENTRAL INDEX KEY: 0001900988 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15925 FILM NUMBER: 24755322 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0001108109 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133893191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-465-7000 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/ DATE OF NAME CHANGE: 20000229 4 1 ownership.xml 4 X0508 4 2024-03-15 0001108109 COMMUNITY HEALTH SYSTEMS INC CYH 0001900988 Pitt Justin D 4000 MERIDIAN BOULEVARD FRANKLIN TN 37067 false true false false EVP and General Counsel false Common Stock 2024-03-15 4 D false 5001 0 D 12584 I By spouse Common Stock 208116 D Performance Based Restricted 0 Common Stock 30000 30000 D Performance Based Restricted 0 Common Stock 30000 30000 D Performance Based Restricted 0 Common Stock 30000 30000 D Stock Options (Right to Buy) 4.99 2020-03-01 2029-02-28 Common Stock 5000 5000 D Stock Options (Right to Buy) 4.93 2021-03-01 2030-02-28 Common Stock 20000 20000 D Stock Options (Right to Buy) 8.81 2022-03-01 2031-02-28 Common Stock 20000 20000 D Stock Options (Right to Buy) 10.18 2023-03-01 2032-02-29 Common Stock 30000 30000 D Stock Options (Right to Buy) 6.15 2024-03-01 2033-02-28 Common Stock 30000 30000 D Stock Options (Right to Buy) 2.87 2025-03-01 2034-02-28 Common Stock 30000 30000 D The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Christopher G. Cobb, Attorney in Fact for Justin D. Pitt 2024-03-15